TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29619643

Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy for Child Abuse and Neglect (MST‐CAN)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Enhanced outpatient treatment
Number of subjects: 86
Study: 26852290

Group type: EXPERIMENTAL
Intervention: Physician-pharmacist collaborative model (PPCM)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 169
Study: 1590572

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg and flunitrazepam 0.5 mg p.o. given at 10:00 p.m. on the evening prior to surgery
Number of subjects: 38

Group type: COMPARATOR
Intervention: Flunitrazepam alone (Control)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Famotidine treatment group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 22108447

Group type: EXPERIMENTAL
Intervention: Esomeprazole (20 mg nocte)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Famotidine (40 mg nocte)
Number of subjects: 311
Study: 20438539

Group type: EXPERIMENTAL
Intervention: Concomitant administration of sevelamer and calcium carbonate
Number of subjects: 14

Group type: COMPARATOR
Intervention: Separate administration of sevelamer and calcium carbonate
Number of subjects: 14
Study: 18777767

Group type: EXPERIMENTAL
Intervention: Unscented Nasonex
Number of subjects: 216

Group type: COMPARATOR
Intervention: Scented Nasonex
Number of subjects: 216
Study: 15963197

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg once daily for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 60
Study: 12372452

Group type: EXPERIMENTAL
Intervention: GnRH analog (GnRH‐a) therapy for 6 months after surgery
Number of subjects: 110

Group type: COMPARATOR
Intervention: 3 cycles of ART alone immediately after surgery
Number of subjects: 110
Study: 10631414

Group type: EXPERIMENTAL
Intervention: Group P50: propofol 1% 10 ml/thiopentone 2.5% 10 ml
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group P75: propofol 1% 15 ml/thiopentone 2.5% 5 ml
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group P100: propofol 1% 20 ml/lignocaine 1% 4 ml
Number of subjects: 90
Study: 7860943

Group type: EXPERIMENTAL
Intervention: Experimental group (n = 45) received instruction on reducing their intake of fat using current dietary recommendations.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 61
Study: 2013178

Group type: EXPERIMENTAL
Intervention: 5 mg of acute sublingual nitrendipine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Short-term oxygen application at rest
Number of subjects: 11

Group type: COMPARATOR
Intervention: 10 mg of nitrendipine once daily for 3 weeks
Number of subjects: 11
Study: 6496911

Group type: EXPERIMENTAL
Intervention: 5% lignocaine and prilocaine cream applied for 20 minutes or longer
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 5% lignocaine and prilocaine cream
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 28900859

Group type: EXPERIMENTAL
Intervention: Surah Al‐Rehman recited by Qari Abdul Basit, 12 structured group sessions of 22 min, two times a day for 4 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Music used for relaxation and treatment of depression, 12 structured group sessions of 22 min, two times a day for 4 weeks
Number of subjects: 12
Study: 29203355

Group type: EXPERIMENTAL
Intervention: drisapersen 6 mg/kg/week
Number of subjects: 186

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 186
Study: 26433369

Group type: EXPERIMENTAL
Intervention: Plan My Life (PML)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Solution-Focused Therapy (SFT)
Number of subjects: 159
Study: 24643315

Group type: EXPERIMENTAL
Intervention: Adherence support interventions (individual counselling and structured theory-based adherence support program)
Number of subjects: 889
Study: 22884052

Group type: EXPERIMENTAL
Intervention: Mask preconditioning (MaG)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Midazolam pretreatment (MiG)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Combination of mask preconditioning and midazolam (Ma/MiG)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Saline group (SaG)
Number of subjects: 160
Study: 21337773

Group type: EXPERIMENTAL
Intervention: Educational program about Ca, PO4 and PTH metabolism
Number of subjects: 33

Group type: COMPARATOR
Intervention: Information on vascular access (Control)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study: 17279847

Group type: EXPERIMENTAL
Intervention: Abstract meaning manipulation of compliments
Number of subjects: 3
Study: 17204525

Group type: EXPERIMENTAL
Intervention: Mild stimulation regimen using GnRH antagonist co‐treatment (67 patients)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Conventional high‐dose exogenous gonadotrophin regimen and GnRH agonist co‐treatment (44 patients)
Number of subjects: 111
Study: 15700748

Group type: EXPERIMENTAL
Intervention: 25 ml olive oil with high phenolic content
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 25 ml olive oil with moderate phenolic content
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 25 ml olive oil with low phenolic content
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 25 ml olive oil with moderate and high phenolic content
Number of subjects: 12
Study: 10855596

Group type: EXPERIMENTAL
Intervention: Delirium present
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Delirium persisted at 1 month
Number of subjects: 126
Study: 9186538

Group type: EXPERIMENTAL
Intervention: G-CSF and 200 IU/kg of EPO (group L)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: G-CSF and 400 IU/kg of EPO (group H)
Number of subjects: 131

Group type: COMPARATOR
Intervention: G-CSF alone (group C)
Number of subjects: 131
Study: 1590582

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.5%
Number of subjects: 146

Group type: COMPARATOR
Intervention: lidocaine 2%
Number of subjects: 146
Study: 2418302

Group type: EXPERIMENTAL
Intervention: Nicardipine (20-30 mg three times daily)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nicardipine (with pindolol as second-step treatment)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (with pindolol as second-step treatment)
Number of subjects: 15
Study: 30746532

Group type: EXPERIMENTAL
Intervention: Comprehensive oral health care
Number of subjects: 187

Group type: COMPARATOR
Intervention: Oral health examination (Control)
Number of subjects: 187
Study: 28012485

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg/day)
Number of subjects: 478

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 478
Study: 25299536

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (designed physical therapy program)
Number of subjects: 30
Study: 23202590

Group type: EXPERIMENTAL
Intervention: Silicone tape
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Paper tape
Number of subjects: 28

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 28
Study: 21570659

Group type: EXPERIMENTAL
Intervention: PRP
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study: 18812844

Group type: EXPERIMENTAL
Intervention: Ropivacaine hydrochloride, 0.2 mg/kg, by submucous infiltration of the proposed incisional site
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no medication before surgery)
Number of subjects: 20
Study: 17181880

Group type: EXPERIMENTAL
Intervention: Strength training (n=12)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (n=6)
Number of subjects: 18
Study: 12709722

Group type: EXPERIMENTAL
Intervention: Itraconazole, 200 mg once daily for 5 days with 10 mg rosuvastatin coadministered on day 4 (trial A)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Itraconazole, 200 mg once daily for 5 days with 80 mg rosuvastatin coadministered on day 4 (trial B)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 11766002

Group type: EXPERIMENTAL
Intervention: Rubella IgG antibody testing using ELISA technique
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Age group 15-20 years
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Age group 31-36 years
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Age group >36 years
Number of subjects: 609

Group type: COMPARATOR
Intervention: Housewives vs service-holders
Number of subjects: 609
Study: 8605125

Group type: EXPERIMENTAL
Intervention: Amniotomy followed by oxytocin infusion after 1 h (group A, n = 98)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Amniotomy alone (group B, n = 98)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Amniotomy followed by oxytocin infusion (group A)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Amniotomy alone (group B)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 196
Study: 1622981

Group type: EXPERIMENTAL
Intervention: Chicken sandwich made with white bread
Number of subjects: 11

Group type: COMPARATOR
Intervention: Chicken sandwich made with wholemeal bread
Number of subjects: 11
Study: 3903783

Group type: EXPERIMENTAL
Intervention: Modified 'Rotahaler'
Number of subjects: 396

Group type: COMPARATOR
Intervention: Standard model 'Rotahaler'
Number of subjects: 396
Study: 30587926

Group type: EXPERIMENTAL
Intervention: Vardenafil hydrochloride (20 mg tablets)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30567826

Group type: EXPERIMENTAL
Intervention: Plaster cast immobilisation
Number of subjects: 478

Group type: COMPARATOR
Intervention: Functional brace
Number of subjects: 478

Group type: EXPERIMENTAL
Intervention: Quality of life and resource use
Number of subjects: 478
Study: 27783767

Group type: EXPERIMENTAL
Intervention: Oral sedation with midazolam
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral sedation with midazolam/ketamine
Number of subjects: 50

Group type: COMPARATOR
Intervention: No sedative
Number of subjects: 50

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 50
Study: 24684966

Group type: EXPERIMENTAL
Intervention: Toric intraocular lens (IOL) implantation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Astigmatic keratotomy (AK)
Number of subjects: 34
Study: 22893340

Group type: EXPERIMENTAL
Intervention: Nurse practitioner and pharmacist consultations
Number of subjects: 120
Study: 20377476

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg and simvastatin 20 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ezetimibe or combination of ezetimibe and simvastatin
Number of subjects: 0
Study: 17616486

Group type: EXPERIMENTAL
Intervention: Tailored Internet
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Tailored Print
Number of subjects: 249

Group type: COMPARATOR
Intervention: Standard Internet
Number of subjects: 249
Study: 15086174

Group type: EXPERIMENTAL
Intervention: En-bloc spleno-pancreatic and vascular resection with adjuvant locoregional chemoimmunotherapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Palliative gastro-biliary bypass with adjuvant locoregional chemoimmunotherapy
Number of subjects: 56
Study: 11324984

Group type: EXPERIMENTAL
Intervention: INS365 ophthalmic solution (0.5%, 1.0%, 2.0%, 5.0%)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: INS365 ophthalmic solution (5.0%)
Number of subjects: 50

Group type: COMPARATOR
Intervention: INS365 ophthalmic solution
Number of subjects: 50
Study: 10374509

Group type: EXPERIMENTAL
Intervention: Early enteral feeding (EFg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed feeding (DFg)
Number of subjects: 0
Study: 8433151

Group type: EXPERIMENTAL
Intervention: AGM-1470 treatment
Number of subjects: 348

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 348
Study: 3630929

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (IS-5MN) 20 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (IS-5MN) 40 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 30260376

Group type: EXPERIMENTAL
Intervention: 15% paromomycin in Aquaphilic
Number of subjects: 80

Group type: COMPARATOR
Intervention: Aquaphilic vehicle
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intralesional pentamidine
Number of subjects: 80
Study: 30328688

Group type: EXPERIMENTAL
Intervention: Pycnogenol supplementation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 30
Study: 25923226

Group type: EXPERIMENTAL
Intervention: Automatic Continuous Positive Airway Pressure (ACPAP)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Optimum Continuous Positive Airway Pressure (CPAP)
Number of subjects: 161
Study: 24472342

Group type: EXPERIMENTAL
Intervention: CIEMR (Circumferential Incision EMR)
Number of subjects: 59

Group type: COMPARATOR
Intervention: EMR (Conventional EMR)
Number of subjects: 59
Study: 22082706

Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioral therapy (TCBT)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Graded exercise
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 442

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 442
Study: 21133303

Group type: EXPERIMENTAL
Intervention: Assessment and management of cardiovascular risk factors by general practitioners and practice nurses
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Advice for high risk patients to exercise more
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Management of obesity/overweight, pre-diabetes, and high lipids
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Provision of dietary advice and referral
Number of subjects: 63
Study: 17613798

Group type: EXPERIMENTAL
Intervention: Higher working memory capacity (WMC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower working memory capacity (WMC)
Number of subjects: 0
Study: 15774253

Group type: EXPERIMENTAL
Intervention: Sildenafil 50mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Apomorphine SL 2mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12368971

Group type: EXPERIMENTAL
Intervention: Daily movement (passive range of motion with gentle compression of both the upper and lower extremities, 5 days per week for 4 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Daily movement
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no daily movement)
Number of subjects: 20
Study: 10606278

Group type: EXPERIMENTAL
Intervention: Diverse treatments including radiation therapy, surgery, chemotherapy, and supportive measures
Number of subjects: 0
Study: 8712751

Group type: EXPERIMENTAL
Intervention: 1 mg Keyhole limpet hemocyanin (KLH) intracutaneously followed by 20 mg KLH intravesically in 20 ml saline for 6 weeks, then monthly for one year and bimonthly for 2 subsequent years
Number of subjects: 9
Study: 1930698

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer dentifrice (0.3% triclosan, 2.0% Gantrez copolymer, 0.243% sodium fluoride/silica)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo dentifrice (0.243% sodium fluoride/silica)
Number of subjects: 108
Study: 6759814

Group type: EXPERIMENTAL
Intervention: Anapsos 120 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 31599965

Group type: EXPERIMENTAL
Intervention: Hard water (> 257 mg L−1 CaCO3)
Number of subjects: 1303

Group type: COMPARATOR
Intervention: Soft water (≤ 257 mg L−1 CaCO3)
Number of subjects: 1303

Group type: EXPERIMENTAL
Intervention: Hard water plus FLG mutations
Number of subjects: 1303

Group type: EXPERIMENTAL
Intervention: Hard water
Number of subjects: 1303
Study: 30136029

Group type: EXPERIMENTAL
Intervention: Carnosine 1g twice daily for 12 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 28193198

Group type: EXPERIMENTAL
Intervention: Microfinance combined with gender training
Number of subjects: 1049
Study: 25929612

Group type: EXPERIMENTAL
Intervention: Micafungin (1 mg/kg for candidiasis, 1 to 3 mg/kg for aspergillosis, up to 6 mg/kg once daily if required)
Number of subjects: 201
Study: 24526760

Group type: EXPERIMENTAL
Intervention: Standard duration intervention program (17 sessions, 1.5 months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Brief intervention program (11 sessions, 1 month)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wait-list group (control)
Number of subjects: 20
Study: 22470539

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 30280

Group type: COMPARATOR
Intervention: Chlorthalidone
Number of subjects: 30280

Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 30280

Group type: EXPERIMENTAL
Intervention: NOS3 -690 C>T (rs3918226)
Number of subjects: 30280

Group type: EXPERIMENTAL
Intervention: NOS3 -922 A>G (rs1800779)
Number of subjects: 30280
Study: 19364294

Group type: EXPERIMENTAL
Intervention: EFA supplementation (480 mg of linoleic acid and 120 mg of alpha-linolenic acid)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (1000 mg of vitamin C)
Number of subjects: 73
Study: 17263800

Group type: EXPERIMENTAL
Intervention: Oral liarozole 75 mg in the morning and 75 mg in the evening for 12 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Acitretin 10 mg in the morning and 25 mg in the evening for 12 weeks
Number of subjects: 32
Study: 15529729

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Ropivacaine
Number of subjects: 54
Study: 10839585

Group type: EXPERIMENTAL
Intervention: Abacavir (ABC) + Stable Background Therapy (SBG)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Stable Background Therapy (SBG) alone
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Abacavir (ABC) + SBG
Number of subjects: 185
Study: 9175045

Group type: EXPERIMENTAL
Intervention: Infusion of 200 units of 1,34‐PTH
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham infusion
Number of subjects: 10
Study: 8267303

Group type: EXPERIMENTAL
Intervention: Trained classroom teachers
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: PE specialists
Number of subjects: 550

Group type: COMPARATOR
Intervention: Control (usual PE)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: All interventions (trained teachers and PE specialists)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: PE intervention
Number of subjects: 550
Study: 3921124

Group type: EXPERIMENTAL
Intervention: Relaxation group (taught breathing exercises, relaxation, meditation, and stress management)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (received health education leaflets only)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Relaxation group
Number of subjects: 192
Study: 2853194

Group type: EXPERIMENTAL
Intervention: rHuIFN‐gamma (2 Mu i.n. 3 x /day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 31752544

Group type: EXPERIMENTAL
Intervention: Active (blue‐light filtering glasses)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (glasses without filtering properties)
Number of subjects: 30
Study: 30338774

Group type: EXPERIMENTAL
Intervention: EPDS (Edinburgh Postnatal Depression Scale)
Number of subjects: 1204

Group type: EXPERIMENTAL
Intervention: Three-factor model (anxiety, depression, anhedonia) confirmed by CFA
Number of subjects: 1204
Study: 28394665

Group type: COMPARATOR
Intervention: Q-switched Nd:YAG laser (1064 nm) alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of ablative ultrapulse CO2 followed by fixed-dose QS Nd:YAG laser (1064 nm)
Number of subjects: 60
Study: 26289682

Group type: EXPERIMENTAL
Intervention: Active Music Therapy (MT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Individualized Listening to Music (LtM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups (MT, LtM, SC)
Number of subjects: 120
Study: 24090805

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 21936956

Group type: EXPERIMENTAL
Intervention: Weekly low dose zoledronic acid
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional dosage of zoledronic acid
Number of subjects: 60
Study: 18179855

Group type: EXPERIMENTAL
Intervention: Carisolv treatment for 30 seconds followed by excavation with a dental explorer
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bristle brush with prophylaxis paste
Number of subjects: 50
Study: 17015541

Group type: EXPERIMENTAL
Intervention: Diphtheria-tetanus-acellular pertussis vaccine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Reduced-antigen content diphtheria-tetanus-acellular pertussis vaccine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control arm (opposite arm)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 12
Study: 12580803

Group type: EXPERIMENTAL
Intervention: Advice from doctors and MIEC (group B)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Advice from doctors only (group A)
Number of subjects: 378
Study: 10885356

Group type: EXPERIMENTAL
Intervention: Tafenoquine 31.25 mg
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Tafenoquine 62.5 mg
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Tafenoquine 125 mg
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Tafenoquine 250 mg
Number of subjects: 426

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 426
Study: 9112147

Group type: EXPERIMENTAL
Intervention: Irritable bowel syndrome group
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 31
Study: 8490010

Group type: EXPERIMENTAL
Intervention: Selenomethionine (200 micrograms Se as Se‐enriched yeast)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Selenate (brewer's yeast mixed with selenate)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (no added Se)
Number of subjects: 33